Title: Crystallization and preliminary X-ray diffraction analysis of the Fab portion of the Alzheimer's disease immunotherapy candidate bapineuzumab complexed with amyloid-beta
Authors: Crespi, GAN
Ascher, DB
Parker, MW
Miles, LA
Issue Year: 2014
Publisher WILEY-BLACKWELL
Series ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY AND CRYSTALLIZATION COMMUNICATIONS: 70(Pt 3):374-7
Abstract Bapineuzumab (AAB-001) and its derivative (AAB-003) are humanized versions of the anti-A beta murine antibody 3D6 and are immunotherapy candidates in Alzheimer's disease. The common Fab fragment of these immunotherapies has been expressed, purified and crystallized in complex with beta-amyloid peptides (residues 1-8 and 1-28). Diffraction data at high resolution were acquired from crystals of Fab-A beta(8) (2.0 angstrom) and Fab-A beta(28) (2.2 angstrom) complexes at the Australian Synchrotron. Both crystal forms belonged to the primitive orthorhombic space group P2(1)22(1).
URI: https://publications.svi.edu.au/publications/1769
Other Identifiers 10.1107/S2053230X14001642
Publication type Article
Grant ID GNT1021645; GNT1021935
Find it online not available
Download Download publication